STAT1 and colorectal carcinoma: In addition, the current study also revealed the specific molecular mechanism of butyrate in upregulating PD-L1 expression via INF-γ–STAT1–PD-L1, which in turn facilitates the immune clearance of CRC and suppresses tumor progression.